Close Menu
    Trending
    • DR Congo secures 70,000 doses for Ebola outbreak
    • Japan trade reaches records with imports leading exports
    • Wall Street rebounds on lower yields and healthcare surge
    • Magnitude 6.1 quake shakes Indonesia near South Nias
    • STS Digital Launches Cross-Asset Portfolio Margin for Institutional Digital Asset Trading
    • Congo Ebola outbreak passes 5,000 cases as response grows
    • DRC Ebola outbreak hits record with 2,325 deaths
    • DRC malaria toll nears 30,000 deaths after 26 million cases
    • Home
    • Contact Us
    Nihon ReportNihon Report
    Sunday, August 23
    • Automotive
    • Business
    • Entertainment
    • Health
    • Luxury
    • Lifestyle
    • News
    • Sports
    • Technology
    • Travel
    Nihon ReportNihon Report
    Home » Brewing hope – how used coffee grounds may combat Alzheimer’s and Parkinson’s
    Health

    Brewing hope – how used coffee grounds may combat Alzheimer’s and Parkinson’s

    November 22, 2023
    Facebook WhatsApp Twitter Pinterest LinkedIn Telegram Tumblr Email Reddit VKontakte

    In the relentless battle against neurodegenerative disorders such as Alzheimer’s, Parkinson’s, and Huntington’s, a groundbreaking discovery emerges from The University of Texas at El Paso. Researchers, exploring the unlikeliest of sources—spent coffee grounds—have unearthed a potential weapon against these debilitating conditions that afflict millions and strain healthcare budgets with hundreds of billions in annual costs.

    Brewing hope - how used coffee grounds may combat Alzheimer's and Parkinson's

    Leading the charge is Jyotish Kumar, a doctoral student in the Department of Chemistry and Biochemistry, along with Mahesh Narayan, Ph.D., a distinguished professor and Royal Society of Chemistry Fellow. Their team has identified caffeic-acid based Carbon Quantum Dots (CACQDs), derivable from used coffee grounds, as a promising agent in shielding brain cells from damage typically associated with neurodegenerative diseases, particularly those exacerbated by factors like obesity, aging, and exposure to environmental toxins.

    Their findings, detailed in the journal Environmental Research, mark a significant leap forward. “CACQDs could revolutionize neurodegenerative disease treatment,” Kumar states. Unlike existing therapies that merely manage symptoms, CACQDs aim at the root causes – the molecular triggers of these ailments. Neurodegenerative diseases, characterized by neuron loss, impair basic and complex functions—from movement and speech to cognitive abilities.

    Lifestyle and environmental factors in early stages of these diseases often lead to increased free radicals and amyloid protein fragment aggregation in the brain, contributing to the progression of these conditions. Kumar’s team discovered that CACQDs offer neuroprotection in various models of Parkinson’s disease, particularly those induced by the pesticide paraquat. The CACQDs demonstrated an ability to neutralize free radicals and prevent amyloid protein aggregation, all without notable side effects.

    This breakthrough suggests that early intervention with CACQD-based treatments could thwart the full onset of diseases like Alzheimer’s and Parkinson’s. Caffeic acid, a polyphenol known for its antioxidant properties, is uniquely capable of crossing the blood-brain barrier, thus directly impacting brain cells. The team’s “green chemistry” approach to extracting CACQDs from coffee waste—cooking grounds at 200° for four hours—is both eco-friendly and cost-effective, making this a sustainable solution.

    The project, encompassing contributions from numerous UTEP graduate and undergraduate students, including Sofia Delgado, now a Ph.D. student at Yale University, signifies a collective effort in scientific advancement. While Narayan and Kumar acknowledge the journey ahead is long, the potential of developing a simple, pill-based preventative treatment for the majority of non-genetically caused neurodegenerative disorders remains a beacon of hope.

    Related Posts

    DR Congo secures 70,000 doses for Ebola outbreak

    August 21, 2026

    Congo Ebola outbreak passes 5,000 cases as response grows

    August 19, 2026

    DRC malaria toll nears 30,000 deaths after 26 million cases

    August 17, 2026

    DR Congo Ebola outbreak passes 1,900 deaths

    August 11, 2026

    Obesity linked to 8.2% of Belgium deaths national study shows

    August 8, 2026

    New Ebola vaccine enters human trial as Congo cases rise

    August 5, 2026
    Featured Posts

    DR Congo secures 70,000 doses for Ebola outbreak

    August 21, 2026

    Japan trade reaches records with imports leading exports

    August 21, 2026

    Wall Street rebounds on lower yields and healthcare surge

    August 20, 2026

    Magnitude 6.1 quake shakes Indonesia near South Nias

    August 19, 2026
    © 2026 Nihon Report | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.